newsfilter
← Latest News
GlobeNewswire·

Blue Water Vaccines Reports Second Quarter 2022 Financial Results and Recent Business Highlights

Closed private placement in April 2022, with net proceeds of approximately $6.9 million Signed multiple strategic agreements and collaborations to further vaccine candidate research, development, and manufacturing $22.2 million in cash as of June 30,